Unidrug Innovative Pharma Technologies Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Unidrug Innov.Pharma

DeciZen not available for IPO

10 Year X-Ray of Unidrug Innov.Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
ROCE % 10.9%9.2%9.8%7.6%10.3%9.1%9.6%10.5%24.7%40.1%-
Value Creation
Index
-0.2-0.3-0.3-0.5-0.3-0.4-0.3-0.30.81.9-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 23.723.419.220.623.92927.726.232.530.931
Sales YoY Gr.--1.1%-18.1%7.4%16.2%21.3%-4.6%-5.3%23.9%-5.1%-
Adj EPS 0.20.40.71.20.10.70.20.32.34.24.2
YoY Gr.-94.7%94.6%69.4%-95.1%1016.7%-65.7%34.8%625.8%84.9%-
BVPS (₹) 5.55.75.96.16.36.56.76.98.81320.5
Adj Net
Profit
0.10.30.60.900.50.20.21.73.23
Cash Flow from Ops. 000004.8012.2-0.7-
Debt/CF from Ops. 000001.303.71.2-6.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3%5.2%3.7%-5.1%
Adj EPS 40.9%133.5%162.5%84.9%
BVPS10.2%15.6%24.7%47.6%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19TTM
Return on
Equity %
3.56.712.320.10.910.53.54.528.738.125.1
Op. Profit
Mgn %
4.65.49.2115.45.83.93.58.416NAN
Net Profit
Mgn %
0.61.22.94.50.21.80.70.95.310.310.4
Debt to
Equity
1.51.51.6221.20.80.70.40.5-
Working Cap
Days
1551732322422191821831671451740
Cash Conv.
Cycle
788112014211883596152850

Recent Performance Summary

Recent Performance Summary not available for IPO

Recent Performance Summary not available for IPO

Latest Financials - Unidrug Innovative Pharma Technologies Ltd.

Standalone Consolidated
TTM EPS (₹) 4.2 -
TTM Sales (₹ Cr.) 30.9 -
BVPS (₹.) 20.5 -
Reserves (₹ Cr.) 8 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 7.7
Face Value (₹) 10
Industry PE 47

Management X-Ray of Unidrug Innov.Pharma:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Unidrug Innov.Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Sales23.6823.4319.1820.5923.9329.0327.7126.2332.5030.86
Operating Expenses 22.5922.3017.9319.4822.6527.8926.6225.3229.9025.93
Manufacturing Costs3.403.672.653.1803.850.783.975.295.84
Material Costs18.2517.1714.0314.1317.4722.4121.4719.1621.0217.13
Employee Cost 0.270.340.370.470.580.610.661.121.611.78
Other Costs 0.671.120.881.694.601.023.701.081.991.17
Operating Profit 1.091.131.241.111.281.141.090.912.614.93
Operating Profit Margin (%) 4.6%4.8%6.5%5.4%5.4%3.9%3.9%3.5%8.0%16.0%
Other Income 0.280.120.120.120.430.160.140.270.070.16
Interest 0.750.780.910.881.280.950.710.610.230.31
Depreciation 0.240.270.250.240.230.140.260.230.180.28
Exceptional Items 00000000-0.220
Profit Before Tax 0.370.200.200.100.190.210.260.342.054.50
Tax 0.120.020.01-0.050.060.070.080.110.551.28
Profit After Tax 0.260.180.190.150.130.140.180.231.493.22
PAT Margin (%) 1.1%0.8%1.0%0.7%0.5%0.5%0.6%0.9%4.6%10.4%
Adjusted EPS (₹)0.30.20.30.20.20.20.20.32.04.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19

Equity and Liabilities

Shareholders Fund 4.184.364.564.714.834.975.155.286.779.99
Share Capital 1.971.971.971.971.971.971.971.971.971.97
Reserves 2.222.402.592.742.873.013.193.314.808.02
Minority Interest0000000000
Debt6.256.467.359.409.685.884.053.652.724.46
Long Term Debt6.256.461.692.651.981.541.110.780.600.96
Short Term Debt005.666.757.694.342.942.872.123.49
Trade Payables3.813.964.173.754.937.156.364.806.793.64
Others Liabilities 0.741.110.730.621.060.950.731.341.491.11
Total Liabilities 14.9915.9016.8018.4820.5118.9516.3015.0617.7819.20

Fixed Assets

Gross Block5.115.055.034.774.985.095.405.745.616.11
Accumulated Depreciation1.621.741.952.082.312.402.662.862.943.10
Net Fixed Assets3.493.313.082.692.672.692.742.872.673.01
CWIP 0000000000.07
Investments 0.220.220.220.220.220.220.220.2200
Inventories3.403.144.414.625.696.303.692.133.284.41
Trade Receivables5.216.927.118.799.637.257.417.869.199.57
Cash Equivalents 0.600.740.770.960.830.740.820.450.880.95
Others Assets2.071.571.211.211.461.751.421.541.761.20
Total Assets 14.9915.9016.8018.4820.5118.9516.3015.0617.7819.20

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19
Cash Flow From Operating Activity 4.7500.982.19-0.72
PBT 0.2100.342.054.50
Adjustment 1.0200.781.250.54
Changes in Working Capital 3.560-0.05-0.88-4.5
Tax Paid -0.040-0.08-0.23-1.26
Cash Flow From Investing Activity -0.100-0.34-0.59-0.64
Capex -0.170-0.40-0.64-0.70
Net Investments 00000
Others 0.0700.050.050.06
Cash Flow From Financing Activity -4.750-1.01-1.161.42
Net Proceeds from Shares 00000
Net Proceeds from Borrowing -0.440-0.33-0.180.36
Interest Paid -0.950-0.61-0.23-0.31
Dividend Paid 00000
Others -3.350-0.06-0.751.37
Net Cash Flow -0.090-0.370.440.06
PARTICULARSMar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Ratios
ROE (%)6.334.34.273.292.662.843.544.524.7838.44
ROCE (%)10.859.219.797.610.39.129.5610.5324.7140.13
Asset Turnover Ratio1.681.521.171.171.341.631.571.671.981.67
PAT to CFO Conversion(x)18.2705.1614.6-5.5400000
Working Capital Days
Receivable Days7994133141129969710696111
Inventory Days49517280726866403045
Payable Days61831061029198115106101111

Unidrug Innovative Pharma Technologies Ltd Stock News

Unidrug Innovative Pharma Technologies Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Unidrug Innov.Pharma on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Unidrug Innov.Pharma stood at ₹0.00.
The latest P/E ratio of Unidrug Innov.Pharma as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Unidrug Innov.Pharma as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Unidrug Innov.Pharma is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Unidrug Innov.Pharma is ₹30.86 ( Cr.) .

About Unidrug Innovative Pharma Technologies Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.